Gian Life Care Limited last traded at ₹4.35 (2026-10-13). Over the past month the stock moved -8.8%, three months the stock moved -28.5%, year the stock moved -72.4%. Its closing range over 52 weeks is ₹4.26 – ₹12.99, with the latest close 66.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2018, Gian Lifecare Ltd is in the business of independent diagnostic/pathological laboratories[1]
Business Overview:[1] GLL provides diagnostic and healthcare testing services across Kanpur and nearby cities. It offers patient diagnosis, prevention, and wellness services to individuals and healthcare providers. The company is expanding its network with new diagnostic labs nationwide. In addition to its major lab in Kanpur, its Lucknow lab became fully operational in FY23.
In the latest quarter (Dec 2025), Gian Life Care Limited reported sales of ₹1.12 crore (-29.6%) and net profit of ₹0.10 crore (-71.4%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Dec 2025 | 1.12 | 0.25 | 22.32 | 0.10 | 0.10 |
| Sep 2025 | 0.66 | -0.41 | -62.12 | -0.51 | -0.49 |
| Jun 2025 | 0.87 | 0.13 | 14.94 | 0.05 | 0.05 |
| Mar 2025 | 1.11 | -0.01 | -0.90 | -0.60 | -0.58 |
| Dec 2024 | 1.59 | 0.47 | 29.56 | 0.35 | 0.34 |
| Sep 2024 | 1.95 | 0.21 | 10.77 | 0.12 | 0.12 |
| Jun 2024 | 1.98 | 0.22 | 11.11 | 0.09 | 0.09 |
| Mar 2024 | 4.60 | 3.05 | 66.30 | 2.13 | 2.06 |
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +196.8% | -18.5% | -15.2% | -58.0% | -75.9% | -56.1% | -66.2% | -29.6% |
| Operating profit growth | – | -56.9% | -36.4% | -78.6% | -100.3% | -40.9% | -295.2% | -46.8% |
| Net profit growth | – | -65.4% | -40.0% | -77.4% | -128.2% | -44.4% | -525.0% | -71.4% |
| EPS growth | – | -64.0% | -36.8% | -77.3% | -128.2% | -44.4% | -508.3% | -70.6% |
| OPM % | 66.3% | 11.1% | 10.8% | 29.6% | -0.9% | 14.9% | -62.1% | 22.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2025), Gian Life Care Limited reported sales of ₹5.94 crore (-53.5%) and net profit of ₹0.16 crore (-96.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2025 | 5.94 | 0.95 | 15.99 | 0.16 | 0.15 |
| Mar 2024 | 12.78 | 6.20 | 48.51 | 4.30 | 4.16 |
| Mar 2023 | 11.41 | 2.04 | 17.88 | 1.26 | 1.22 |
| Mar 2022 | 15.45 | 6.06 | 39.22 | 4.37 | 4.23 |
| Mar 2021 | 10.24 | 3.10 | 30.27 | 2.02 | 1.96 |
| Mar 2020 | 7.31 | 2.08 | 28.45 | 1.13 | 1.10 |
| Mar 2019 5m | 0.56 | 0.20 | 35.71 | 0.10 | – |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Sales growth | +1205.4% | +40.1% | +50.9% | -26.1% | +12.0% | -53.5% |
| Operating profit growth | +940.0% | +49.0% | +95.5% | -66.3% | +203.9% | -84.7% |
| Net profit growth | +1030.0% | +78.8% | +116.3% | -71.2% | +241.3% | -96.3% |
| EPS growth | – | +78.2% | +115.8% | -71.2% | +241.0% | -96.4% |
| OPM % | 28.5% | 30.3% | 39.2% | 17.9% | 48.5% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Gian Life Care Limited.
Get Free AI Stock Analysis FREE →No recent news available for Gian Life Care Limited.
Gian Life Care Limited shares were last quoted at ₹4.35 (+1.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Gian Life Care Limited has a price-to-earnings (P/E) ratio of -6.09 and a price-to-book (P/B) ratio of 0.25. The industry P/E is 99.89.
The 52-week high of Gian Life Care Limited is ₹16.19 and the 52-week low is ₹4.49.
The market capitalisation of Gian Life Care Limited is about ₹4.66 crore.
In the latest quarter (Dec 2025), Gian Life Care Limited reported sales of ₹1.12 crore (-29.6%) and net profit of ₹0.10 crore (-71.4%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Gian Life Care Limited has a 3-year ROE of 10.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 30.17% of Gian Life Care Limited.
Gian Life Care Limited belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z